'The main outcomes of mortality, initiation of ventilation and hospitalization duration were not clearly reduced,' the study reads.
The antiviral drug remdesivir had little or no effect in treating patients hospitalized with Covid-19, according to a study that has not yet been peer reviewed, but was coordinated by the World Health Organization and released on29 June 2020, Egypt, Giza: Packs containing vials of Remdesivir, a broad-spectrum antiviralmedication approved as a specific treatment for COVID-19, lie next to an employee of Egyptian pharmaceutical company Eva Pharma at the company's factory, which started...
"The main outcomes of mortality, initiation of ventilation and hospitalization duration were not clearly reduced by any study drug," the study reads.Regimens involving the anti-malarial drug hydroxychloroquine have already been proven ineffective, but remdesivir appeared to be one of the few therapies to prove effective in combating Covid-19 symptoms.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump’s Drug-Discount Cards Expected to Reach Medicare Recipients After ElectionPresident Trump’s plan to send 33 million Medicare beneficiaries a card that can be used to help pay for up to $200 in prescription drug costs won’t be completed until after the election, according to a person familiar with the plan
Read more »
The alarming reason people aren't going to drug stores as oftenPeople aren't going to such chains as much as they used to — and one of the reasons is alarming to some medical experts.
Read more »
Sharp Rise In Drug Overdose Deaths Seen During 1st Few Months Of PandemicDrug overdose deaths rose roughly 10% in the first 3 months of this year, preliminary CDC data shows, offering the first official view of the pandemic's impact on Americans suffering addiction.
Read more »
Regeneron's drug becomes first FDA-approved Ebola virus treatmentThe drugmaker has said it is now talking with the FDA about an emergency use authorisation for its experimental dual antibody cocktail for Covid-19.
Read more »
Regeneron's drug becomes first FDA-approved Ebola virus treatmentThe U.S. Food and Drug Administration on Wednesday approved Regeneron Pharmaceuticals' triple antibody cocktail as the first Ebola virus treatment, lending validation to similar drugs being developed for COVID-19.
Read more »
Eli Lilly says other COVID-19 antibody drug trials ongoing after study halted for safety concernEli Lilly & Co on Wednesday said other trials of its experimental coronavirus antibody therapy remain on track after a government-run study testing the treatment in hospitalized COVID-19 patients was paused due to safety concerns.
Read more »